11C-BF-227

N/A

Report date: 2025/11/25 15:56:45

NME

Base Information

Drug Name11C-BF-227

Drug Alias Name[11C]BF-22711C-BF-227

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Carbon > 11CDiagnostic agent (In vivo) > Radionuclide Imaging agent +[5]

Mechanisms of ActionAnti-APP

TargetsBeta amyloid A4 protein

Therapy Area/IndicationsDiagnostic agents

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesTohoku University

China Registration ClassN/A

Develop Information

Active CompaniesTohoku University

Inactive CompaniesN/A

Active IndicationsDiagnostic agents

Inactive IndicationsN/A

Other Information

ATC CodeN/A